$3.21
-0.022-0.68%
Last update: Oct 27, 10:40 AM
MannKind Corp (MNKD) Stock Price, Quote, News & History
MNKDNASDAQ
MannKind Corp. (NASDAQ: MNKD) reported strong Q4 and FY 2025 results, with earnings and sales beating expectations.
You can purchase shares of MannKind (NASDAQ:MNKD) through any online brokerage.
Other companies in MannKind’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
MannKind has a consensus price target of $9.10.
The stock price for MannKind (NASDAQ: MNKD) is $3.208 last updated October 27, 2026 at 10:40 AM EDT.
There are no upcoming dividends for MannKind.
MannKind does not have any upcoming earnings scheduled.
There is no upcoming split for MannKind.
MannKind is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
MannKind Corp is a biopharmaceutical company dedicated to transforming chronic disease care through patient-centric solutions. Focused on cardiometabolic and orphan lung diseases, it develops and commercializes treatments that address unmet medical...
